HISTORAM benefits of € 50000 from the OncoStarter funding program of CLARA, Cancéropôle Lyon Auvergne Rhône-Alpes, for the translational innovative and original research in oncology in order to strength the preliminary results and demonstrate the feasibility of the project.

In this context, OncoStarter funding allowed to complete last technical developments achieving the first prototype version of the device, to realize the analysis algorithm and to strength the collaboration with medical teams. In particular, we currently collaborate with CHU Grenoble Alpes for the maturation and valorisation phase.

Furthermore, OncoStarter drives the visibility of HISTORAM in the medical environment giving the possibility of partnerships and collaborations. We consider the role of CLARA as a key factor for the successful creation of the start-up.

To know more about this funding program, click here.